SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    G.L. Maxwell, J.M. Schildkraut, B. Calingaert, J.I. Risinger, L. Dainty, P.A. Marchbanks, A. Berchuck, J.C. Barrett, G.C. Rodriguez, Progestin and estrogen potency of combination oral contraceptives and endometrial cancer risk, Gynecologic Oncology, 2006, 103, 2, 535

    CrossRef

  2. 2
    Leslie Bernstein, The Risk of Breast, Endometrial and Ovarian Cancer in Users of Hormonal Preparations, Basic & Clinical Pharmacology & Toxicology, 2006, 98, 3
  3. 3
    S.J. de Visser, N. Uchida, E. van Vliet-Daskalopoulou, I. Fukazawa, M.B.A. van Doorn, M.W. van den Heuvel, C.S.M. Machielsen, E. Uchida, A.F. Cohen, Pharmacokinetic differences between Caucasian and Japanese subjects after single and multiple doses of a potential combined oral contraceptive (Org 30659 and EE), Contraception, 2003, 68, 3, 195

    CrossRef

  4. 4
    June La Valleur, Susan Wysocki, Selection of oral contraceptives or hormone replacement therapy: Patient communication and counseling issues, American Journal of Obstetrics and Gynecology, 2001, 185, 2, S57

    CrossRef

  5. 5
    &NA;, The Pill and cancer, European Journal of Cancer Prevention, 2000, 9, 4, 219

    CrossRef

  6. 6
    Linda S. Cook, Noel S. Weiss, Women and Health, 2000,

    CrossRef

  7. 7
    David F Archer, Endometrial histology during use of a low-dose estrogen-desogestrel oral contraceptive with a reduced hormone-free interval, Contraception, 1999, 60, 3, 151

    CrossRef

  8. 8
    Philip C. Hannaford, Combined oral contraceptives: Do we know all of their effects?, Contraception, 1995, 51, 6, 325

    CrossRef

  9. 9
    David B. Thomas, Roberta M. Ray, Depot-medroxyprogesterone acetate (DMPA) and risk of invasive adenocarcinomas and adenosquamous carcinomas of the uterine cervix, Contraception, 1995, 52, 5, 307

    CrossRef

  10. 10
    David A. Grimes, Katherine E. Economy, Primary prevention of gynecologic cancers, American Journal of Obstetrics and Gynecology, 1995, 172, 1, 227

    CrossRef

  11. 11
    Lynda F. Voigt, Qiang Deng, Noel S. Weiss, Recency, duration, and progestin content of oral contraceptives in relation to the incidence of endometrial cancer (Washington, USA), Cancer Causes & Control, 1994, 5, 3, 227

    CrossRef

  12. 12
    D. B. Thomas, Contraceptivos orales y cáncer, Advances in Contraception, 1993, 9, S1, 31

    CrossRef

  13. 13
    B.L.G. Kneale, G.G. Giles, Endometrial Cancer: Trends in Incidence and Survival: A Preventable Disease?, Australian and New Zealand Journal of Obstetrics and Gynaecology, 1993, 33, 1
  14. 14
    Janet L. Stanford, Louise A. Brinton, Robert N. Hoover, Michael L. Berman, Rodrigue Mortel, Leo B. Twiggs, Rolland J. Barrett, George D. Wilbanks, Oral contraceptives and endometrial cancer: Do other risk factors modify the association?, International Journal of Cancer, 1993, 54, 2